ProText Mobility, Inc. (TXTM)
OTCMKTS · Delayed Price · Currency is USD
0.0047
+0.0001 (1.08%)
Aug 5, 2025, 3:59 PM EDT
ProText Mobility Company Description
ProText Mobility, Inc., a biotech company, engages in the development of pharmaceutical botanical medicines.
Its medicines are formulated with highly-bioavailable plant extracts. The company is based in Fort Lauderdale, Florida.
ProText Mobility, Inc. operates as a subsidiary of Plandaí Biotechnology, Inc.
ProText Mobility, Inc.
| Country | United States |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Roger Baylis-Duffield |
Contact Details
Address: One West Las Olas Blvd. Fort Lauderdale, 33301 United States | |
| Website | protxtm.com |
Stock Details
| Ticker Symbol | TXTM |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Reporting Currency | USD |
| ISIN Number | US74371E2046 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Roger Baylis-Duffield | Chairman, President and Chief Executive Officer |